A ground-breaking new wireless pacemaker technology, which could benefit the world’s 1.5m heart failure patients, has received European CE Mark approval.
The company responsible for the innovative wireless pacemaker, EBR Systems, has received CE marking approval for its WiSE (Wireless Stimulation Endocardially) Technology. WiSE Technology is reportedly the world’s first and only wireless endocardial (inside the heart) pacing system for cardiac resynchronization therapy (CRT). CRT is a treatment for heart failure that uses an implantable pacemaker…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
